UN I

TED STATES OF AME RICA DEPAR TM E NT OF TRAN S PORTATION FEDERAL AVIATION ADMINISTRATION WASHINGTON, DC 20591 In the matter of the petition of Caribbean Sun Airlines, Inc d/b/a World Atlantic Airlines Regulatory Docket No. FAA

- 2013

- 0034 for an exemptio n from 121.803 (c) (3) and Part 121, Appendix A, paragraph (2) of Title 14, Code of Federal Regulations
PARTIAL GRANT OF EXEMPTION World Atlantic Airlines, with a mailing address of P.O. Box 660479, Miami Springs FL, 33266 and a physical address of 5600 NW 36th Street, Miami, FL 33166 is petitioning the Federal Aviation Administration (FAA) for an exemption from CFR 121.803(c)(3) and Appendix A of CFR 121, Title 14, Code of Federal Regulations. The proposed exemption, if granted, wo uld provide relief from the requirement to include Atropine in an Emergency Medical Kit (EMK). This petition is due to a nationwide manufacturing supply shortage that leaves affected certificate holders without an alternate means to comply with the requirements of Appendix A. Wo rld Atlantic Airlines requires relief from the following regulations: Section 121.803(c))(3) prescribes, in pertinent part, that passenger - carrying airplanes operating under part 121 rules for which a flight attendant is required must have approved emerge ncy medical kits that meet the specifications and requirements of Part 121, Appendix A. Part 121, Appendix A, "Emergency Medical Kits" specifies, in pertinent part, that an EMK must include two single dose ampules of Atropine 0.5, Sec injectable or equivalent. World Atlantic Airlines supports its request with the following information: Atropine, a medication required to be carried in EMKs, is not available due to a manufacturing shortfall and an increase in demand. Our major EMK supplier has indicated that its Atropine supply has been depleted. As such, we will not be able to meet the atropine requirement. World Atlantic Airlines has attached a letter from our emergency equipment provider, Aerospace Accessory Service, Inc., concerning the unavailability of Atropine as evidence of the Atrop ine shortag e
. Further to this, weare aware of the four pharmaceutical com panies that manufacture Atropine and that one manufacturer has decided to stop producing Atropine and another has decided to indefinitely postpone Atropine production. T his lack of production has resulted in two remaining manufact

urers rati o ning remai ning supplies to fir st

- line respond ers suc h as hospitals and paramedic units. Finally, World Atlantic Airlines requests that they be able to exercise the privileges of the exem ption outside the United States

. The International Civil Aviation Organization (ICAO) standards require aircraft authorized to carry mo re than 100 p assengers to be equipped with " accessible and adequate medical supplies," but recomme nds that injectable Atropine be available as part of a medical kit for use by medical doctors or other qualified persons on certain aircraft. Accordingly, we believe that the absence of Atropine in an EMK on an aircraft operating outside the United States wo uld not violate ICAO requirements. For the above stated reasons, World Atlantic Airlines is requesting an exem ption from 121.803 (c) (3) and Part 121, Appendix A, paragraph (2) of Title 14, Code of Federal Regulations. 

### Sincerely, 

# John Rupert V.P. / Director of Operations Caribbean Sun Airlines, Inc. d/b/a World Atlantic Airlines (305) 722

- 6118